Page last updated: 2024-08-24

cidofovir anhydrous and Male Genitourinary Diseases

cidofovir anhydrous has been researched along with Male Genitourinary Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beylot-Barry, M; Blaizot, R; Dutkiewicz, AS; Guillet, S; Pham-Ledard, A1
Beltrame, A; Carosi, G; Casalini, C; Ciravolo, G; Forleo, MA; Graifemberghi, S; Gulletta, M; Matteelli, A; Tedoldi, S1
Descamps, V; Mahé, E1

Trials

2 trial(s) available for cidofovir anhydrous and Male Genitourinary Diseases

ArticleYear
Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons.
    Sexually transmitted diseases, 2001, Volume: 28, Issue:6

    Topics: Administration, Cutaneous; Adult; Antiviral Agents; Anus Diseases; Cidofovir; Cytosine; Female; Female Urogenital Diseases; HIV Infections; Humans; Male; Male Urogenital Diseases; Organophosphonates; Organophosphorus Compounds; Patient Satisfaction; Pilot Projects; Single-Blind Method; Treatment Outcome; Tumor Virus Infections; Warts

2001
[A new antiviral for genito-anal condylomas].
    Presse medicale (Paris, France : 1983), 2002, Mar-16, Volume: 31, Issue:10

    Topics: Administration, Topical; Adult; Antiviral Agents; Cidofovir; Condylomata Acuminata; Cytosine; Double-Blind Method; Female Urogenital Diseases; Humans; Male Urogenital Diseases; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Treatment Outcome; Tumor Virus Infections

2002

Other Studies

1 other study(ies) available for cidofovir anhydrous and Male Genitourinary Diseases

ArticleYear
Intravenous cidofovir for diffuse genital warts in the setting of multifactorial immunosuppression.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2017, Volume: 31, Issue:3

    Topics: Antiviral Agents; Cidofovir; Condylomata Acuminata; Humans; Injections, Intravenous; Male; Male Urogenital Diseases; Middle Aged

2017